Oscar Health Stock Rebounds as Investors Anticipate Earnings Report
Written by Emily J. Thompson, Senior Investment Analyst
Updated: 1h ago
0mins
Should l Buy OSCR?
Source: stocktwits
- Quarterly Earnings Expectations: Wall Street anticipates Oscar Health's Q4 revenue to reach $3.12 billion, up from $2.99 billion in the previous quarter, although losses are expected to widen with adjusted EBITDA losses projected at $217.8 million, significantly increasing from $101.5 million a year earlier, highlighting the company's challenges in balancing revenue growth with profitability.
- Analyst Rating Changes: UBS upgraded Oscar from 'Sell' to 'Neutral' and raised its price target from $12 to $17, citing better-than-expected enrollment despite the expiration of enhanced premium subsidies, indicating that the market may be valuing Oscar fairly at current levels.
- Market Sentiment Analysis: According to Stocktwits data, retail investor sentiment for Oscar Health is 'bullish' with high message volume, as investors note the company has surpassed EPS expectations 75% of the time over the past year, reflecting optimism ahead of the upcoming earnings report.
- ACA Enrollment Trends: While Oscar expresses confidence in returning to profitability by 2026, ACA enrollment has decreased from 24.3 million to 22.8 million, indicating potential pressures on long-term growth due to the impact of subsidy expirations on market dynamics.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy OSCR?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on OSCR
Wall Street analysts forecast OSCR stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for OSCR is 17.04 USD with a low forecast of 11.00 USD and a high forecast of 25.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
7 Analyst Rating
1 Buy
4 Hold
2 Sell
Hold
Current: 12.240
Low
11.00
Averages
17.04
High
25.00
Current: 12.240
Low
11.00
Averages
17.04
High
25.00
About OSCR
Oscar Health, Inc. is a healthcare technology company built around a full stack technology platform. The Company's offerings include its insurance business and +Oscar Platform. Its health plans are offered in the individual market. The individual market primarily consists of policies purchased by individuals and families through health insurance marketplaces, established by the ACA and operated by the federal government, as well as other marketplaces operated by individual states. Individuals and families may also purchase policies in the individual market off-exchange. Employees whose employers have chosen to offer an Individual Coverage Health Reimbursement Arrangement (ICHRA) are also able to purchase its health plans. It offers health plans in the individual market under the five metal plan categories defined by the ACA: Catastrophic, Bronze, Silver, Gold, and Platinum. Through the +Oscar platform, the Company deploys its technology to help others throughout the healthcare system.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Oscar Health to Announce Q4 Earnings on February 10
- Earnings Announcement: Oscar Health is set to release its Q4 earnings on February 10 before the market opens, with a consensus EPS estimate of -$0.92 and a revenue estimate of $3.12 billion, reflecting a 30.5% year-over-year growth, which could significantly impact the company's stock performance.
- Performance Expectations: Over the past year, Oscar Health has beaten EPS estimates 75% of the time, while only achieving 25% for revenue estimates, indicating considerable volatility in profitability that may affect investor confidence moving forward.
- Estimate Revision Trends: In the last three months, EPS estimates have seen five upward revisions and two downward, while revenue estimates have experienced seven upward revisions with none downward, suggesting a growing market confidence in Oscar Health's future growth potential, which could attract more investor interest.
- Market Environment Impact: With the increase in Obamacare enrollment, Oscar Health faces a dilemma of high growth and high risk; while the company has potential for market share expansion, it must navigate the uncertainties brought about by policy changes.
See More
Oscar Health Stock Rebounds as Investors Anticipate Earnings Report
- Quarterly Earnings Expectations: Wall Street anticipates Oscar Health's Q4 revenue to reach $3.12 billion, up from $2.99 billion in the previous quarter, although losses are expected to widen with adjusted EBITDA losses projected at $217.8 million, significantly increasing from $101.5 million a year earlier, highlighting the company's challenges in balancing revenue growth with profitability.
- Analyst Rating Changes: UBS upgraded Oscar from 'Sell' to 'Neutral' and raised its price target from $12 to $17, citing better-than-expected enrollment despite the expiration of enhanced premium subsidies, indicating that the market may be valuing Oscar fairly at current levels.
- Market Sentiment Analysis: According to Stocktwits data, retail investor sentiment for Oscar Health is 'bullish' with high message volume, as investors note the company has surpassed EPS expectations 75% of the time over the past year, reflecting optimism ahead of the upcoming earnings report.
- ACA Enrollment Trends: While Oscar expresses confidence in returning to profitability by 2026, ACA enrollment has decreased from 24.3 million to 22.8 million, indicating potential pressures on long-term growth due to the impact of subsidy expirations on market dynamics.
See More
High-Volume Earnings Reports This Week from Tech and Consumer Sectors
- Earnings Schedule: This week features a high volume of earnings reports from technology, consumer discretionary, and energy sectors, with RIVN stock showing notable movement ahead of its earnings release, indicating investor sentiment.
- Monday.com and Pagaya Reports: On Monday, work management SaaS provider Monday.com and fintech company Pagaya released their earnings before the market opened, with expectations that their results will reflect broader industry trends.
- Coinbase Earnings Expectations: On Thursday, Coinbase is expected to report earnings of 68 cents per share and quarterly revenue of $1.86 billion, despite facing a projected 33% drop in transaction revenue, raising investor interest in its growing stablecoin and subscription services.
- Nebius Group Forecast: Also on Thursday, Nebius Group is projected to report a loss of $1.14 per share and revenue of $246.05 million, with analysts expressing caution, reflecting concerns over cloud service demand in the current market environment.
See More
Key Earnings Reports and Economic Outlook This Week
- DuPont Earnings Expectations: DuPont is expected to report earnings of $0.43 per share and revenue of $1.69 billion for Q4 2025, with analysts noting ongoing pressure in short-cycle businesses, while slight improvements in the automotive sector may influence investor sentiment.
- Cisco's AI Focus: Cisco anticipates earnings of $1.02 per share and revenue of $15.1 billion for Q2 FY2026, with CEO highlighting a major multi-year campus networking refresh, making AI infrastructure demand a critical growth driver.
- Importance of Employment Report: The January employment report is expected to show an addition of 80,000 nonfarm payrolls and an unchanged unemployment rate of 4.4%, directly impacting private consumption and U.S. GDP, making it crucial for investors to monitor.
- Consumer Price Index Insights: The January CPI is projected to increase by 2.5% year-over-year, with core CPI rising by 2.6%, providing essential inflation details despite not being the Fed's preferred measure, particularly regarding persistent shelter cost inflation.
See More
Oscar Health: AI-Driven Innovation in Health Insurance
- Market Share Growth: Oscar Health's paying member count surged from 200,000 in 2019 to 2 million, demonstrating robust growth in the individual market, with expectations for this trend to continue, further solidifying its market position.
- Tech-Driven Insurance Platform: By offering complimentary telehealth services and cloud-based software, Oscar Health enhances customer satisfaction and reduces costs, which is expected to become a standard feature in health insurance by 2026, strengthening its competitive edge.
- Price Adjustments to Address Challenges: In response to rising healthcare costs in 2025, Oscar Health has raised its insurance plan prices by 28%, aiming to restore profitability; while facing potential customer loss in the short term, the long-term outlook remains optimistic.
- Revenue Expectations and Market Valuation: Oscar Health anticipates generating $12 billion in revenue this year against a market cap of under $4 billion, making the current valuation attractive for long-term investors if the company can successfully adjust pricing and return to profitability.
See More
Oscar Health Faces Short-Term Challenges but Long-Term Potential Remains
- Market Share Growth: Oscar Health's paying members surged from 200,000 in 2019 to 2 million, indicating robust growth in the individual health insurance market despite facing short-term pressures from rising healthcare costs.
- Tech-Driven Innovation: The company has launched an AI chatbot named Oswell, powered by OpenAI, aimed at helping members manage their healthcare information more efficiently, thereby enhancing customer satisfaction and reducing operational costs.
- Pricing Adjustment Strategy: Oscar Health plans to raise insurance plan prices by 28% in 2026 to address profitability pressures stemming from rising healthcare costs and the expiration of subsidies, with expectations that this strategy will help restore profitability.
- Revenue Expectations: Although currently unprofitable, Oscar Health anticipates generating $12 billion in revenue this year against a market cap of under $4 billion, suggesting that the current stock price may be undervalued, presenting an attractive opportunity for long-term investors.
See More
Oscar Health to Announce Q4 Earnings on February 10
- Earnings Announcement: Oscar Health is set to release its Q4 earnings on February 10 before the market opens, with a consensus EPS estimate of -$0.92 and a revenue estimate of $3.12 billion, reflecting a 30.5% year-over-year growth, which could significantly impact the company's stock performance.
- Performance Expectations: Over the past year, Oscar Health has beaten EPS estimates 75% of the time, while only achieving 25% for revenue estimates, indicating considerable volatility in profitability that may affect investor confidence moving forward.
- Estimate Revision Trends: In the last three months, EPS estimates have seen five upward revisions and two downward, while revenue estimates have experienced seven upward revisions with none downward, suggesting a growing market confidence in Oscar Health's future growth potential, which could attract more investor interest.
- Market Environment Impact: With the increase in Obamacare enrollment, Oscar Health faces a dilemma of high growth and high risk; while the company has potential for market share expansion, it must navigate the uncertainties brought about by policy changes.
See More
Oscar Health Stock Rebounds as Investors Anticipate Earnings Report
- Quarterly Earnings Expectations: Wall Street anticipates Oscar Health's Q4 revenue to reach $3.12 billion, up from $2.99 billion in the previous quarter, although losses are expected to widen with adjusted EBITDA losses projected at $217.8 million, significantly increasing from $101.5 million a year earlier, highlighting the company's challenges in balancing revenue growth with profitability.
- Analyst Rating Changes: UBS upgraded Oscar from 'Sell' to 'Neutral' and raised its price target from $12 to $17, citing better-than-expected enrollment despite the expiration of enhanced premium subsidies, indicating that the market may be valuing Oscar fairly at current levels.
- Market Sentiment Analysis: According to Stocktwits data, retail investor sentiment for Oscar Health is 'bullish' with high message volume, as investors note the company has surpassed EPS expectations 75% of the time over the past year, reflecting optimism ahead of the upcoming earnings report.
- ACA Enrollment Trends: While Oscar expresses confidence in returning to profitability by 2026, ACA enrollment has decreased from 24.3 million to 22.8 million, indicating potential pressures on long-term growth due to the impact of subsidy expirations on market dynamics.
See More
High-Volume Earnings Reports This Week from Tech and Consumer Sectors
- Earnings Schedule: This week features a high volume of earnings reports from technology, consumer discretionary, and energy sectors, with RIVN stock showing notable movement ahead of its earnings release, indicating investor sentiment.
- Monday.com and Pagaya Reports: On Monday, work management SaaS provider Monday.com and fintech company Pagaya released their earnings before the market opened, with expectations that their results will reflect broader industry trends.
- Coinbase Earnings Expectations: On Thursday, Coinbase is expected to report earnings of 68 cents per share and quarterly revenue of $1.86 billion, despite facing a projected 33% drop in transaction revenue, raising investor interest in its growing stablecoin and subscription services.
- Nebius Group Forecast: Also on Thursday, Nebius Group is projected to report a loss of $1.14 per share and revenue of $246.05 million, with analysts expressing caution, reflecting concerns over cloud service demand in the current market environment.
See More
Key Earnings Reports and Economic Outlook This Week
- DuPont Earnings Expectations: DuPont is expected to report earnings of $0.43 per share and revenue of $1.69 billion for Q4 2025, with analysts noting ongoing pressure in short-cycle businesses, while slight improvements in the automotive sector may influence investor sentiment.
- Cisco's AI Focus: Cisco anticipates earnings of $1.02 per share and revenue of $15.1 billion for Q2 FY2026, with CEO highlighting a major multi-year campus networking refresh, making AI infrastructure demand a critical growth driver.
- Importance of Employment Report: The January employment report is expected to show an addition of 80,000 nonfarm payrolls and an unchanged unemployment rate of 4.4%, directly impacting private consumption and U.S. GDP, making it crucial for investors to monitor.
- Consumer Price Index Insights: The January CPI is projected to increase by 2.5% year-over-year, with core CPI rising by 2.6%, providing essential inflation details despite not being the Fed's preferred measure, particularly regarding persistent shelter cost inflation.
See More
Oscar Health: AI-Driven Innovation in Health Insurance
- Market Share Growth: Oscar Health's paying member count surged from 200,000 in 2019 to 2 million, demonstrating robust growth in the individual market, with expectations for this trend to continue, further solidifying its market position.
- Tech-Driven Insurance Platform: By offering complimentary telehealth services and cloud-based software, Oscar Health enhances customer satisfaction and reduces costs, which is expected to become a standard feature in health insurance by 2026, strengthening its competitive edge.
- Price Adjustments to Address Challenges: In response to rising healthcare costs in 2025, Oscar Health has raised its insurance plan prices by 28%, aiming to restore profitability; while facing potential customer loss in the short term, the long-term outlook remains optimistic.
- Revenue Expectations and Market Valuation: Oscar Health anticipates generating $12 billion in revenue this year against a market cap of under $4 billion, making the current valuation attractive for long-term investors if the company can successfully adjust pricing and return to profitability.
See More
Oscar Health Faces Short-Term Challenges but Long-Term Potential Remains
- Market Share Growth: Oscar Health's paying members surged from 200,000 in 2019 to 2 million, indicating robust growth in the individual health insurance market despite facing short-term pressures from rising healthcare costs.
- Tech-Driven Innovation: The company has launched an AI chatbot named Oswell, powered by OpenAI, aimed at helping members manage their healthcare information more efficiently, thereby enhancing customer satisfaction and reducing operational costs.
- Pricing Adjustment Strategy: Oscar Health plans to raise insurance plan prices by 28% in 2026 to address profitability pressures stemming from rising healthcare costs and the expiration of subsidies, with expectations that this strategy will help restore profitability.
- Revenue Expectations: Although currently unprofitable, Oscar Health anticipates generating $12 billion in revenue this year against a market cap of under $4 billion, suggesting that the current stock price may be undervalued, presenting an attractive opportunity for long-term investors.
See More
